Moderna Stock Over 16% Up So Far On Monday
Moderna set to file for us, EU clearance for its coronavirus vaccine. According to today’s article on ForexLive, “Moderna reaffirms that its vaccine is 94.1% effective in primary analysis – Vaccine was 94.1% effective in analysis of Phase 3 study, after 196 virus cases – Vaccine was 100% effective against strict virus cases in trial…